Peripheral blood eosinophil count as a biomarker of exacerbation in stable chronic obstructive pulmonary disease outpatients: a prospective observational study

Background Peripheral blood eosinophil count is liable to many factors and has variability over time. There are few studies on the association between the rise of blood eosinophils and the exacerbation incidence in stable chronic obstructive pulmonary disease (COPD) patients. The association between...

Full description

Bibliographic Details
Main Authors: Tarek Safwat, Mohammed El-Sheikh, Amira Ali El-Sayed, Dalia Abd-Elsattar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2023;volume=72;issue=3;spage=313;epage=319;aulast=Safwat
_version_ 1797738792608595968
author Tarek Safwat
Mohammed El-Sheikh
Amira Ali El-Sayed
Dalia Abd-Elsattar
author_facet Tarek Safwat
Mohammed El-Sheikh
Amira Ali El-Sayed
Dalia Abd-Elsattar
author_sort Tarek Safwat
collection DOAJ
description Background Peripheral blood eosinophil count is liable to many factors and has variability over time. There are few studies on the association between the rise of blood eosinophils and the exacerbation incidence in stable chronic obstructive pulmonary disease (COPD) patients. The association between the rise of blood eosinophils and the rate of exacerbation in stable COPD patients is controversial. Objective To study the relationship between the count of eosinophils in the peripheral blood and the incidence of COPD exacerbation in stable patients. Patients and methods This prospective inquiry was done on 46 patients diagnosed as suffering from stable COPD ‘on the report of the global initiative for chronic obstructive lung disease (GOLD) guidelines’ attending Ain Shams University hospital outpatient clinic. Results Forty-six stable COPD patients were classified into two groups (groups A and B) based on their median eosinophilic count of ‘250 cell/μl.’ Patients with high eosinophil count ‘group A’ (>250 cell/μl) had a significantly higher incidence of exacerbations (P=0.003), with a relative risk ratio of 2.77, as well as a higher number of exacerbations per patient (two exacerbations/patient) versus one exacerbation/three patients (P<0.001), and a shorter period to the first exacerbation (17 vs. 31 days) (P=0.024), compared with those with low eosinophil count ‘group B (≤250 cell/μl)’ during the study period. On the contrary, there was no significant difference between them in the incidence of pneumonia in relation to inhaled corticosteroid use. Conclusion The count of eosinophils in the peripheral blood is a reliable exacerbation biomarker in stable COPD patients.
first_indexed 2024-03-12T13:48:55Z
format Article
id doaj.art-4fc91728263041e39d51aee32b9debf3
institution Directory Open Access Journal
issn 0422-7638
2090-9950
language English
last_indexed 2024-03-12T13:48:55Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Egyptian Journal of Chest Disease and Tuberculosis
spelling doaj.art-4fc91728263041e39d51aee32b9debf32023-08-23T07:29:34ZengWolters Kluwer Medknow PublicationsEgyptian Journal of Chest Disease and Tuberculosis0422-76382090-99502023-01-0172331331910.4103/ecdt.ecdt_120_22Peripheral blood eosinophil count as a biomarker of exacerbation in stable chronic obstructive pulmonary disease outpatients: a prospective observational studyTarek SafwatMohammed El-SheikhAmira Ali El-SayedDalia Abd-ElsattarBackground Peripheral blood eosinophil count is liable to many factors and has variability over time. There are few studies on the association between the rise of blood eosinophils and the exacerbation incidence in stable chronic obstructive pulmonary disease (COPD) patients. The association between the rise of blood eosinophils and the rate of exacerbation in stable COPD patients is controversial. Objective To study the relationship between the count of eosinophils in the peripheral blood and the incidence of COPD exacerbation in stable patients. Patients and methods This prospective inquiry was done on 46 patients diagnosed as suffering from stable COPD ‘on the report of the global initiative for chronic obstructive lung disease (GOLD) guidelines’ attending Ain Shams University hospital outpatient clinic. Results Forty-six stable COPD patients were classified into two groups (groups A and B) based on their median eosinophilic count of ‘250 cell/μl.’ Patients with high eosinophil count ‘group A’ (>250 cell/μl) had a significantly higher incidence of exacerbations (P=0.003), with a relative risk ratio of 2.77, as well as a higher number of exacerbations per patient (two exacerbations/patient) versus one exacerbation/three patients (P<0.001), and a shorter period to the first exacerbation (17 vs. 31 days) (P=0.024), compared with those with low eosinophil count ‘group B (≤250 cell/μl)’ during the study period. On the contrary, there was no significant difference between them in the incidence of pneumonia in relation to inhaled corticosteroid use. Conclusion The count of eosinophils in the peripheral blood is a reliable exacerbation biomarker in stable COPD patients.http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2023;volume=72;issue=3;spage=313;epage=319;aulast=Safwatblood eosinophiliastable chronic obstructive pulmonarypatients
spellingShingle Tarek Safwat
Mohammed El-Sheikh
Amira Ali El-Sayed
Dalia Abd-Elsattar
Peripheral blood eosinophil count as a biomarker of exacerbation in stable chronic obstructive pulmonary disease outpatients: a prospective observational study
Egyptian Journal of Chest Disease and Tuberculosis
blood eosinophilia
stable chronic obstructive pulmonary
patients
title Peripheral blood eosinophil count as a biomarker of exacerbation in stable chronic obstructive pulmonary disease outpatients: a prospective observational study
title_full Peripheral blood eosinophil count as a biomarker of exacerbation in stable chronic obstructive pulmonary disease outpatients: a prospective observational study
title_fullStr Peripheral blood eosinophil count as a biomarker of exacerbation in stable chronic obstructive pulmonary disease outpatients: a prospective observational study
title_full_unstemmed Peripheral blood eosinophil count as a biomarker of exacerbation in stable chronic obstructive pulmonary disease outpatients: a prospective observational study
title_short Peripheral blood eosinophil count as a biomarker of exacerbation in stable chronic obstructive pulmonary disease outpatients: a prospective observational study
title_sort peripheral blood eosinophil count as a biomarker of exacerbation in stable chronic obstructive pulmonary disease outpatients a prospective observational study
topic blood eosinophilia
stable chronic obstructive pulmonary
patients
url http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2023;volume=72;issue=3;spage=313;epage=319;aulast=Safwat
work_keys_str_mv AT tareksafwat peripheralbloodeosinophilcountasabiomarkerofexacerbationinstablechronicobstructivepulmonarydiseaseoutpatientsaprospectiveobservationalstudy
AT mohammedelsheikh peripheralbloodeosinophilcountasabiomarkerofexacerbationinstablechronicobstructivepulmonarydiseaseoutpatientsaprospectiveobservationalstudy
AT amiraalielsayed peripheralbloodeosinophilcountasabiomarkerofexacerbationinstablechronicobstructivepulmonarydiseaseoutpatientsaprospectiveobservationalstudy
AT daliaabdelsattar peripheralbloodeosinophilcountasabiomarkerofexacerbationinstablechronicobstructivepulmonarydiseaseoutpatientsaprospectiveobservationalstudy